Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

TBRG earnings analysis

Filed May 8, 2026 · Our reading of the company's report

The latest report

TruBridge, Inc. reported a slight decrease in total revenue for Q1 2026, totaling $86.3 million, down 1% from $87.2 million in Q1 2025. The diluted EPS for the quarter was $0.03, unchanged from the prior year. Alongside…

Read full summary

TruBridge, Inc. reported a slight decrease in total revenue for Q1 2026, totaling $86.3 million, down 1% from $87.2 million in Q1 2025. The diluted EPS for the quarter was $0.03, unchanged from the prior year. Alongside a notable drop in operating income, performance varied across business segments, with Financial Health revenues declining while Patient Care revenues increased due to new SaaS contract growth and increased migration to SaaS models.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

56% Gross margin Operating margin Aug 2023 May 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

From revenue to operating profit

Where each $100 of revenue went in this report.

Of every $100 of revenue Cost of sales $44 Operating expenses $52 Left as operating profit $4

Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Aug 2023 May 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$0.03
Segment
Financial Health
Segment
Patient Care

What stood out

  • Revenue Decline

    Total revenue was $86.3 million, a decrease of 1% from $87.2 million in Q1 2025.

  • Steady EPS Amid Decline

    Diluted EPS remained flat at $0.03 compared to the same quarter last year.

  • Patient Care Growth

    Patient Care revenues grew by 6%, reaching $33.0 million, driven by new SaaS contracts.

  • Cash Flow Improvement

    Net cash provided by operating activities increased by $9.7 million to $15.5 million in Q1 2026.

  • Cost Optimization

    Total costs of revenue decreased by $1.2 million and improved as a percentage of revenue, to 44%.

  • Increased Cash Reserves

    Cash and cash equivalents rose to $35.4 million from $24.9 million at the end of 2025.

What to watch

  • Earnings Miss Expectations

    Actual EPS was -$0.37 vs estimated EPS of $0.51, missing expectations by 1.73%.

  • Financial Health Segment Decline

    Financial Health revenues fell by 5% to $53.3 million due to customer attrition.

  • Pending Merger Risks

    The proposed merger with IKS may not complete, creating uncertainty and operational disruption.

Management's outlook

No explicit forward guidance provided in the filing.

Earlier filings 4

10-K · April 30, 2026

TruBridge's latest 10-K filing provides insights into its strategic vision and ongoing acquisition by IKS Health, which is anticipated to close in Q3 2026. However, the most recent earnings report revealed an EPS of…

10-K · March 31, 2026

TruBridge reported 2025 revenue of $346.8 million (an increase of $4.6 million, or 1%, versus 2024) and turned profitable with net income of $4.4 million (EPS $0.29) after a 2024 net loss of $20.9 million. The business…

10-K · March 17, 2025

TruBridge reported 2024 revenue of $342.6M (up 2.0% YoY) driven by Financial Health, while Patient Care revenues declined after the sale of AHT. Operating income turned positive at $6.6M and operating cash flow improved…

10-Q · November 12, 2024

TruBridge reported Q3 revenue of $83,830 (in thousands), up $1,118 from $82,712 in the prior-year quarter, driven by Financial Health growth. Operating income improved to $1,944 (in thousands) from an operating loss of…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.